GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lumiera Health Inc (TSXV:NHP.H) » Definitions » Cash-to-Debt

Lumiera Health (TSXV:NHP.H) Cash-to-Debt : 0.01 (As of Aug. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Lumiera Health Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Lumiera Health's cash to debt ratio for the quarter that ended in Aug. 2023 was 0.01.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Lumiera Health couldn't pay off its debt using the cash in hand for the quarter that ended in Aug. 2023.

The historical rank and industry rank for Lumiera Health's Cash-to-Debt or its related term are showing as below:

TSXV:NHP.H' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01   Med: 3.05   Max: No Debt
Current: 0.01

During the past 10 years, Lumiera Health's highest Cash to Debt Ratio was No Debt. The lowest was 0.01. And the median was 3.05.

TSXV:NHP.H's Cash-to-Debt is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.93 vs TSXV:NHP.H: 0.01

Lumiera Health Cash-to-Debt Historical Data

The historical data trend for Lumiera Health's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Lumiera Health Cash-to-Debt Chart

Lumiera Health Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Nov18 Nov19 Nov20 Nov21 Nov22
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.90 0.41 2.28 0.63 0.01

Lumiera Health Quarterly Data
Sep18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.01 0.01 0.01 0.01

Competitive Comparison of Lumiera Health's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Lumiera Health's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lumiera Health's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lumiera Health's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Lumiera Health's Cash-to-Debt falls into.



Lumiera Health Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Lumiera Health's Cash to Debt Ratio for the fiscal year that ended in Nov. 2022 is calculated as:

Lumiera Health's Cash to Debt Ratio for the quarter that ended in Aug. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lumiera Health  (TSXV:NHP.H) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Lumiera Health Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Lumiera Health's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Lumiera Health (TSXV:NHP.H) Business Description

Traded in Other Exchanges
N/A
Address
4500 Kimber, Suite 26, Saint-Hubert, QC, CAN, J3Y 8K5
Lumiera Health Inc is a natural health products company. The company is developing products focusing on the endocannabinoid system and providing treatments for chronic pain and inflammation.

Lumiera Health (TSXV:NHP.H) Headlines

No Headlines